Cargando…

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer

BACKGROUND: Low nuclear expression of the RNA-binding motif protein 3 (RBM3) has previously been found to be associated with poor prognosis in several cancer forms e.g. breast, ovarian, colorectal, prostate cancer and malignant melanoma. The aim of this study was to examine the prognostic impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boman, Karolina, Segersten, Ulrika, Ahlgren, Göran, Eberhard, Jakob, Uhlén, Mathias, Jirström, Karin, Malmström, Per-Uno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635919/ https://www.ncbi.nlm.nih.gov/pubmed/23565664 http://dx.doi.org/10.1186/1471-2490-13-17

Ejemplares similares

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
por: Boman, Karolina, et al.
Publicado: (2017)

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
por: Mezheyeuski, Artur, et al.
Publicado: (2020)

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
por: Kerzeli, Iliana K., et al.
Publicado: (2023)

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
por: Valdés, Alberto, et al.
Publicado: (2021)

High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death
por: Jonsson, Liv, et al.
Publicado: (2014)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
por: Fristedt, Richard, et al.
Publicado: (2014)

Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer
por: Andersson, Nina, et al.
Publicado: (2020)

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
por: Chan, Owen T.M., et al.
Publicado: (2017)

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
por: Kerzeli, Iliana K., et al.
Publicado: (2021)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker
por: Wennersten, Christoffer, et al.
Publicado: (2014)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study
por: Jonsson, Liv, et al.
Publicado: (2011)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma
por: Fristedt, Richard, et al.
Publicado: (2014)

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
por: Mezheyeuski, Artur, et al.
Publicado: (2023)

Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
por: Wahlin, Sara, et al.
Publicado: (2019)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
por: Larsson, Anna H, et al.
Publicado: (2013)

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer
por: Olofsson, Sven-Erik, et al.
Publicado: (2015)

An unusual case of asymptomatic non-urothelial bladder tumour
por: Ching, Daniel, et al.
Publicado: (2016)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
por: Furuya, Hideki, et al.
Publicado: (2022)

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome
por: Bengtsson, Erik, et al.
Publicado: (2014)

Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma
por: Lockhart, Kathleen, et al.
Publicado: (2021)

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
por: Nodin, Björn, et al.
Publicado: (2012)

The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness
por: Teleka, Stanley, et al.
Publicado: (2022)

SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma
por: Hedner, Charlotta, et al.
Publicado: (2014)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients
por: AFONSO, JULIETA, et al.
Publicado: (2014)

Mandibular Metastasis of a Recurrent Poorly Differentiated Urothelial Bladder Carcinoma
por: Aoun, Georges, et al.
Publicado: (2020)

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
por: Wahlin, Sara, et al.
Publicado: (2022)

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
por: Koti, Madhuri, et al.
Publicado: (2017)

Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours
por: Llewellyn, Matthew A., et al.
Publicado: (2018)

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
por: Koti, Madhuri, et al.
Publicado: (2018)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study
por: Florianova, Livia, et al.
Publicado: (2015)

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
por: Micke, Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9f2hjqkt9ersv84vjc7d4t7eb